Literature DB >> 10651680

Effect of cricoid pressure on the incidence of nausea and vomiting in the immediate postoperative period.

F A Khan1, A ul Haq.   

Abstract

This study aimed to evaluate whether the application of cricoid pressure at the time of induction of anaesthesia was associated with a lesser incidence of postoperative nausea or vomiting in the immediate postoperative period compared with a group in which no cricoid pressure was applied, in patients undergoing day care gynaecological laparoscopy. One hundred ASA I and II females were randomly allocated to receive cricoid pressure at the time of induction. The peri-operative anaesthetic technique was standardised. The incidence of postoperative nausea and vomiting in the group who received cricoid pressure was 16% in the recovery room compared with 26% in the no cricoid group. When the period was extended to the first 6 h post anaesthesia the incidence was 30% in the cricoid and 44% in the no cricoid group. This difference did not achieve statistical significance in either period (p > 0.05). The results suggest that application of cricoid pressure at the time of induction does not significantly alter the incidence of postoperative nausea and vomiting in the first 6 h of recovery from anaesthesia.

Entities:  

Mesh:

Year:  2000        PMID: 10651680     DOI: 10.1046/j.1365-2044.2000.055002163.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Bispectral index response to cricoid pressure during induction of general anesthesia.

Authors:  Saeed Abbasi; Reihanak Talakoub; Babak Jahangirifard; Mehrdad Masoodifar; Hamid Saryazdi
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

Review 2.  Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation.

Authors:  Catherine M Algie; Robert K Mahar; Hannah B Tan; Greer Wilson; Patrick D Mahar; Jason Wasiak
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.